Cardiomyopathy in Mothers of Boys With Muscular DystrophyCardiomyopathy in Mothers of Boys With Muscular Dystrophy https://pediatricsnationwide.org/wp-content/uploads/2020/09/AdobeStock_93001580-1024x670.jpg 1024 670 Mary Bates, PhD Mary Bates, PhD https://secure.gravatar.com/avatar/c6233ca2b7754ab7c4c820e14eb518c8?s=96&d=mm&r=g
- September 29, 2020
- Mary Bates, PhD
Female carriers of the genetic defect that causes muscular dystrophy in boys show evidence of cardiac fibrosis.
An interdisciplinary team from Nationwide Children’s Hospital reports about half of women who carry the genetic defect responsible for muscular dystrophy show evidence of cardiac fibrosis. The study, published in the International Journal of Cardiology, suggests that cardiac muscle, and not skeletal muscle, is predominantly affected in this population.
Duchenne and Becker muscular dystrophy are progressive neuromuscular diseases caused by mutations in the DMD gene, which encodes the protein dystrophin. About two-thirds of affected boys inherit the mutation in an X-linked recessive pattern from their mothers.
It was thought that female carriers of this mutation would be protected from expressing the disease due to the normal copy of the DMD gene on their second X chromosome. However, some mothers of boys with muscular dystrophy have reported symptoms of muscle weakness and cardiac issues.
In the study, researchers from the departments of cardiology, neurology and psychology collaborated to define this disease and estimate its prevalence. They performed a battery of tests, including cardiac magnetic resonance imaging (MRI) and cardiopulmonary exercise testing, on three groups of women: mothers of sons with muscular dystrophy who were genetically confirmed to carry the mutation, mothers of sons with muscular dystrophy who did not have the mutation, and healthy women.
Cardiac MRI revealed that 49% of the genetic carriers had cardiac fibrosis, as opposed to 5% of the noncarriers and none of the healthy controls.
There were no differences between the genetic carriers and the other two groups on treadmill testing, suggesting the genetic defect predominantly affects cardiac muscle and not skeletal muscle in this population.
The researchers also found that, despite cardiomyopathy, the functional capacity of genetic carriers’ heart muscles was maintained.
May Ling Mah, MD, and Kan Hor, MD, cardiology investigators at The Heart Center at Nationwide Children’s say the findings highlight the importance of genetic testing for mothers of boys with Duchenne and Becker muscular dystrophies.
“We recommend these mothers get gene tested,” she says. “Then, genetically confirmed carriers should have a cardiac MRI by their third decade, and more importantly, a third of them can be reassured.”
This study is part of a larger longitudinal project funded by a grant from Parent Project Muscular Dystrophy. Dr. Mah says that, together, findings from neuromuscular, cognitive and cardiac tests will provide a detailed picture of this disease, as well as its trajectory. Such research could impact mothers and boys with muscular dystrophy.
“What we learn in one of these patient populations can help the other,” she says. “With these moms who are carriers, we have the opportunity to study the same gene defect in a different way.”
Mah ML, Cripe L, Slawinski MK, Al-Zaidy SA, Camino E, Lehman KJ, Jackson JL, Iammarino M, Miller N, Mendell JR, Hor KN. Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing. International Journal of Cardiology. 27 May 2020. [Epub ahead of print]
Image credit: Adobe Stock
About the author
You might also like
Standardizing Training in Pediatric Cardiac Critical CareStandardizing Training in Pediatric Cardiac Critical Care https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Mary Bates, PhD Mary Bates, PhD https://secure.gravatar.com/avatar/c6233ca2b7754ab7c4c820e14eb518c8?s=96&d=mm&r=g
How Patient-Derived Stem Cells are Changing the Trajectory of Congenital Heart Disease ResearchHow Patient-Derived Stem Cells are Changing the Trajectory of Congenital Heart Disease Research https://pediatricsnationwide.org/wp-content/uploads/2021/10/iStock_000014186415XLarge-1024x683.jpg 1024 683 Katie Brind'Amour, PhD, MS, CHES Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gif
Long-Term Follow-up Study Shows Cannabidiol is Safe and Effective for Lennox-Gastaut SyndromeLong-Term Follow-up Study Shows Cannabidiol is Safe and Effective for Lennox-Gastaut Syndrome https://pediatricsnationwide.org/wp-content/uploads/2018/05/Anup-Patel-Environmental.jpg 695 473 Mary Bates, PhD Mary Bates, PhD https://secure.gravatar.com/avatar/c6233ca2b7754ab7c4c820e14eb518c8?s=96&d=mm&r=g